fashion -WSS

fashion

author：explore 2025-10-02 22:58:31 - browse：92

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Wikipedia

WSS

With clinical trial data readouts, here's how to spot spin

Bird flu in milk supply is likely coming from asymptomatic cows

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

What to do when lifesaving products contribute to climate change

Will the market for weight loss drugs really reach $100 billion?

Pediatric cancer treatments threatened by a new FDA policy

entertainment

fashion

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to pay for weight loss drugs and save Medicare

Heart attack and stroke risk calculators need revising

Cigna, Humana reportedly in talks to merge

In Memoriam: Notable people who died in 2023

What to do when lifesaving products contribute to climate change

Anesthesiologist group: stop taking Ozempic before surgery

Diversity in clinical trials starts with building trust, experts say

How one medical school became remarkably diverse

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

focus

U.K. Biobank has 500,000 peoples' genome sequences available

Bird flu outbreak in cows is latest avian flu curveball

Cell therapy fails to slow type 1 diabetes, but safety is established

After traumatic brain injury, life support decisions can use more time

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Bird flu in milk supply is likely coming from asymptomatic cows

Wikipedia

Wikipedia

Wikipedia

entertainment